Cialis

Drug: Cialis
Company: Eli Lilly
Total spend Q1, 2012: $42.3 million
Total spend Q1, 2011: $33.3 million
Watch the TV commercial here >>

The market for erectile dysfunction drugs remains strong and Cialis last year brought Lilly $1.88 billion. That was 8% of the company's revenue, although about half what Lilly generates from its antidepressant Cymbalta, which it also marketed heavily in the first quarter. Cialis earned $207 million in the first quarter, drugs.com reports, up 3.2%. Its patent on Cialis is good in the U.S. until 2017, so Lilly has about 5 more years of promising revenue even as other of its drugs lose protection.

Cialis
Read more on

Suggested Articles

JAK drugs have run into safety issues, and if the label for AbbVie's Rinvoq is any indication, the FDA now believes those the issues are class-wide.

Rather than "we did the best we could," Vas Narasimhan, during an internal call with managers, said Novartis could have handled the Zolgensma crisis…

After five years of struggles, Sun Pharmaceutical has put the problems at its key plant in Halol, India behind it.